Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and 3,5-bis(2-fluorobenzylidene)piperidin-4-one

pyrrolidine dithiocarbamate has been researched along with 3,5-bis(2-fluorobenzylidene)piperidin-4-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, SL; Cong, W; Hou, GG; Sun, Y; Suo, HD; Wang, CH; Wei, H; Xin, WY; Yao, BR; Zhang, YL; Zhao, F	1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and 3,5-bis(2-fluorobenzylidene)piperidin-4-one

Article	Year
Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation. European journal of medicinal chemistry, 2019, Apr-01, Volume: 167 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Design; Heterografts; Humans; Liver Neoplasms, Experimental; Mice; NF-kappa B; Piperidones; Structure-Activity Relationship	2019

Article

Year

Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.

European journal of medicinal chemistry, 2019, Apr-01, Volume: 167

Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Design; Heterografts; Humans; Liver Neoplasms, Experimental; Mice; NF-kappa B; Piperidones; Structure-Activity Relationship

2019